Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Expedia Group Inc (EXPE) vs Humana Inc (HUM) Price & Performance

Expedia Group IncTrade
Humana IncTrade

Price performance (Past 24H)

Key statistics

Expedia Group Inc vs Humana Inc — how do they compare? Expedia Group Inc trades at $265.42 (market cap $32.06B), while Humana Inc trades at $403.98 (market cap $48.96B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays the higher dividend (0.87%). Which is the better fit depends on your goals.

EXPEHUM
Market Cap
$32.06B$48.96B
Sector
Consumer CyclicalHealth
52-Week High
$301.31$409.42
52-Week Low
$178.06$163.67
Enterprise Value
$30.97B$58.00B
Dividend Yield
0.66%0.87%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Expedia Group Inc

Expedia Group (EXPE) trades at $266.28, showing modest daily gains of 0.24%. The stock exhibits a bullish technical signal, supported by strong earnings beats in recent quarters and robust revenue growth from $11.7B in 2022 to $14.7B in 2025. The company maintains high profitability with a 90.27% gross margin and recently announced a strategic partnership with Allegiant Travel Company, expanding its online travel agency network.

The investment outlook is positive with analyst consensus at $292.09, representing 9.7% upside potential. Key opportunities include continued travel sector growth and operational efficiency gains from recent technology investments. Primary risks involve macroeconomic sensitivity affecting travel demand and competitive pressures in the online travel market. The company's strong cash flow generation supports shareholder returns through dividends and potential buybacks.

Humana Inc

Humana (HUM) trades at $406.70, up 0.17% on the day, and is currently above its consensus price target. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company has beaten earnings expectations for three consecutive quarters and is executing a strategic shift from membership growth to profitability, targeting a 3% Medicare Advantage margin by 2028. Revenue has grown consistently from $92.9B in 2022 to $129.7B in 2025.

The outlook is mixed. The company's strategic pivot and recent contract wins like the Illinois Medicaid contract present growth opportunities. However, significant risks include multiple legal investigations into statements on healthcare costs, declining net profit margins (from 3.02% in 2022 to 0.91% in 2025), and a high P/E ratio of 43.52. Analyst sentiment is cautious, with a majority 'Hold' rating and a consensus price target 13% below the current price.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Expedia Group Inc

Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

Read more on EXPE

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM